{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:00:33Z","timestamp":1794412833960,"version":"4.9.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.esmoop.2022.100447","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T13:29:28Z","timestamp":1649251768000},"page":"100447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors"],"prefix":"10.1016","volume":"7","author":[{"given":"S.","family":"Ochsenreither","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.M.","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.D.","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Macchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Habel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Ahrens-Fath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Raspagliesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Keilholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rolling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kebenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.F.","family":"Klinghammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Baumeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zurlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Garralda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.esmoop.2022.100447_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrc1251","article-title":"Mucins in cancer: protection and control of the cell surface","volume":"4","author":"Hollingsworth","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100447_bib2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.molmed.2014.02.007","article-title":"MUC1: a multifaceted oncoprotein with a key role in cancer progression","volume":"20","author":"Nath","year":"2014","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.esmoop.2022.100447_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1476-4598-11-64","article-title":"Cooperative interaction of MUC1 with the HGF\/c-Met pathway during hepatocarcinogenesis","volume":"11","author":"Bozkaya","year":"2012","journal-title":"Mol Cancer"},{"key":"10.1016\/j.esmoop.2022.100447_bib4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.tcb.2006.07.006","article-title":"Cell surface-associated mucins in signal transduction","volume":"16","author":"Singh","year":"2006","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.esmoop.2022.100447_bib5","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/jcb.24580","article-title":"Activated EGFR stimulates MUC1 expression in human uterine and pancreatic cancer cell lines","volume":"114","author":"Dharmaraj","year":"2013","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.esmoop.2022.100447_bib6","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1242\/jcs.062661","article-title":"MUC1 regulates nuclear localization and function of the epidermal growth factor receptor","volume":"123","author":"Bitler","year":"2010","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.esmoop.2022.100447_bib7","doi-asserted-by":"crossref","first-page":"32796","DOI":"10.18632\/oncotarget.8743","article-title":"MUC1 stimulates EGFR expression and function in endometrial cancer","volume":"7","author":"Engel","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.esmoop.2022.100447_bib8","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41388-018-0522-7","article-title":"Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition","volume":"38","author":"de Boer","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.esmoop.2022.100447_bib9","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00262-006-0135-9","article-title":"PankoMab: a potent new generation anti-tumour MUC1 antibody","volume":"55","author":"Danielczyk","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.esmoop.2022.100447_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejca.2016.05.003","article-title":"A\u00a0phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas","volume":"63","author":"Fiedler","year":"2016","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100447_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2017-000303","article-title":"Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas","volume":"3","author":"Fiedler","year":"2018","journal-title":"ESMO Open"},{"issue":"30","key":"10.1016\/j.esmoop.2022.100447_bib12","doi-asserted-by":"crossref","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100447_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000479980","article-title":"Modulating cytotoxic effector functions by Fc engineering to improve cancer therapy","volume":"44","author":"Kellner","year":"2017","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.esmoop.2022.100447_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ctrv.2018.12.006","article-title":"Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies","volume":"73","author":"Mauri","year":"2019","journal-title":"Cancer Treat Rev"}],"updated-by":[{"DOI":"10.1016\/j.esmoop.2022.100549","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000}}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702922000631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702922000631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T20:21:03Z","timestamp":1668802863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702922000631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2059702922000631"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100447","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.esmoop.2022.100549","asserted-by":"object"}]},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100447"}}